ES2119086T3 - Uso de quinonas para la fabricacion de un medicamento para el tratamiento y prevencion de una rinitis alergica. - Google Patents

Uso de quinonas para la fabricacion de un medicamento para el tratamiento y prevencion de una rinitis alergica.

Info

Publication number
ES2119086T3
ES2119086T3 ES94306795T ES94306795T ES2119086T3 ES 2119086 T3 ES2119086 T3 ES 2119086T3 ES 94306795 T ES94306795 T ES 94306795T ES 94306795 T ES94306795 T ES 94306795T ES 2119086 T3 ES2119086 T3 ES 2119086T3
Authority
ES
Spain
Prior art keywords
allergic rhinitis
quinones
prevention
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94306795T
Other languages
English (en)
Inventor
Mitsuru Shiraishi
Yasuko Ashida
Tatsumi Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2119086T3 publication Critical patent/ES2119086T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA PARA TRATAMIENTO O PREVENCION DE RINITIS ALERGICA QUE COMPRENDE UN DERIVADO DE QUINONA O HIDROQUINONA QUE TIENE ANTAGONISMO PARA RECEPTOR DE TROMBOXANO A2. ESTE COMPUESTO ES APENAS INACTIVADO POR METABOLISMO EN VIVO Y PUEDE MANTENER SU NIVEL EFECTIVO EN SANGRE DURANTE LARGO TIEMPO Y EXHIBE EXCELENTE ACTIVIDAD FARMACOLOGICA EN UNA DOSIS BAJA.
ES94306795T 1993-09-21 1994-09-16 Uso de quinonas para la fabricacion de un medicamento para el tratamiento y prevencion de una rinitis alergica. Expired - Lifetime ES2119086T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23509193 1993-09-21
JP32663693 1993-12-24

Publications (1)

Publication Number Publication Date
ES2119086T3 true ES2119086T3 (es) 1998-10-01

Family

ID=26531946

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94306795T Expired - Lifetime ES2119086T3 (es) 1993-09-21 1994-09-16 Uso de quinonas para la fabricacion de un medicamento para el tratamiento y prevencion de una rinitis alergica.

Country Status (9)

Country Link
US (1) US5733929A (es)
EP (1) EP0645137B1 (es)
JP (1) JP2742221B2 (es)
AT (1) ATE168558T1 (es)
CA (1) CA2132479A1 (es)
DE (1) DE69411833T2 (es)
DK (1) DK0645137T3 (es)
ES (1) ES2119086T3 (es)
GR (1) GR3027792T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613309D0 (en) * 1996-06-25 1996-08-28 Univ Sheffield Quinone bacterial inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150014A (en) * 1980-04-21 1981-11-20 Takeda Chem Ind Ltd Antiallergic agent
JPS58177934A (ja) * 1982-04-13 1983-10-18 Takeda Chem Ind Ltd ベンゾキノン誘導体
MX9203040A (es) * 1984-08-01 1992-07-31 Takeda Chemical Industries Ltd Derivados de quinona y composicion farmaceutica que los contiene.
EP0232089B1 (en) * 1986-01-28 1991-03-13 Takeda Chemical Industries, Ltd. Quinone amides, their production and use
JPH0816056B2 (ja) * 1986-10-17 1996-02-21 武田薬品工業株式会社 トロンボキサンａ▲下２▼受容体拮抗剤
ES2090528T3 (es) * 1991-10-15 1996-10-16 Takeda Chemical Industries Ltd Procedimiento para preparar derivados del difenilmetano.
EP0560568A3 (en) * 1992-03-13 1994-06-29 Takeda Chemical Industries Ltd Hydroquinone derivatives and intermediates for production thereof

Also Published As

Publication number Publication date
ATE168558T1 (de) 1998-08-15
DK0645137T3 (da) 1999-04-26
JPH07228526A (ja) 1995-08-29
EP0645137A1 (en) 1995-03-29
EP0645137B1 (en) 1998-07-22
JP2742221B2 (ja) 1998-04-22
GR3027792T3 (en) 1998-11-30
US5733929A (en) 1998-03-31
DE69411833D1 (de) 1998-08-27
DE69411833T2 (de) 1998-12-03
CA2132479A1 (en) 1995-03-22

Similar Documents

Publication Publication Date Title
ES2086270T5 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
DK0773020T3 (da) Farmaceutiske præparater indeholdende L-carnitin eller derivater deraf i kombination med resveratrol eller derivater deraf til forebyggelsen og behandlingen af cardiovaskulære lidelser, perifere vaskulære sygdomme og perifer diabetisk neuropati
KR940006578A (ko) 2-(3,4-디메톡신나모일) 아미노벤조산
WO1994027589A3 (en) Antidepressant dosage form
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
DE69629273D1 (de) Zusammensetzungen enthaltend Propionyl-L-Carnitine und Hydroxyzitronensäure oder Pantothensäure
PT1118325E (pt) Utilizacao de paclitaxel e seus derivados na preparacao de um medicamento para o tratamento de restenose
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
AR035533A1 (es) Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
ES2066790T3 (es) Formulaciones farmaceuticas para evitar la tolerancia a medicamentos.
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
ES2119086T3 (es) Uso de quinonas para la fabricacion de un medicamento para el tratamiento y prevencion de una rinitis alergica.
KR960703593A (ko) (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine)
ITMI932189A1 (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
AU670491C (en) Pharmaceutical for the treatment of skin disorders
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
EP1264601A3 (en) Treatment of a coronary condition by delivery of therapeutics to the pericardial space
KR940003550A (ko) 노인성 치매 예방 및 치료방법
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.
ITMI932219A1 (it) Composizioni farmaceutiche contenenti una sostanza attiva fosfatidilinositolo atte alla terapia delle neurpatie periferiche da

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 645137

Country of ref document: ES